CLINICAL_TRIALS
trial_result
· 2014-07-21
Clinical Trial Update: SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder [Phase 3]
Summary
Phase 3 trial update for SPD489 in adults with moderate to severe binge eating disorder has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Binge Eating Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-07-21